eXoZymes, Inc.
NASDAQ:EXOZ · NASDAQ Global Market
+$1.06 today
Vol 0.02M · Avg 0.01M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-25.43%
Period High
$16.50
Period Low
$6.33
Latest
$7.83
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Greenwich LifeSciences, Inc.
NASDAQ:GLSI
$344.06M
Surrozen, Inc.
NASDAQ:SRZN
$169.06M
Cognition Therapeutics, Inc.
NASDAQ:CGTX
$104.42M
Oncolytics Biotech Inc.
NASDAQ:ONCY
$95.36M
Tiziana Life Sciences Ltd
NASDAQ:TLSA
$65.96M
Instil Bio, Inc.
NASDAQ:TIL
$51.34M
Estrella Immunopharma, Inc.
ESLA
$43.46M
Tevogen Bio Holdings Inc.
TVGN
$42.15M
Atossa Therapeutics, Inc.
ATOS
$17.27M
Anebulo Pharmaceuticals, Inc.
ANEB
$15.92M
What is the latest EXOZ filing?
The latest filing shown is 8-K dated Jun 17, 2026.
How many recent filings does EXOZ have?
Intrinsic Alpha currently shows 20 recent filings for EXOZ.
Explore More
Continue the stock analysis
Jump to another research area for this company.